发明名称 |
LSA-5 liver stage and blood stage antigen of <i>Plasmodium falciparum</i>, immunogenic composition comprising said antigen, and vaccines against malaria |
摘要 |
The present invention pertains to the protection against malaria. More particularly, the invention is based on the characterization of a novel liver and sporozoite-stage P. falciparum antigen, referred to as LSA-5. This antigen is highly antigenic and the prevalence of antibodies in subjects living in endemic areas is extremely high (ca. 90%). The invention concerns antigenic peptides, mixtures thereof, or polypeptides, mixotopes and conjugates comprising part of the sequence of LSA-5, as well as immunogenic compositions, vaccines and kits comprising these. |
申请公布号 |
US8765145(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US200611451324 |
申请日期 |
2006.06.13 |
申请人 |
Vac-4-All Pte. Ltd. |
发明人 |
Druilhe Pierre;Brahimi-Zeghidour Karima |
分类号 |
A61K39/002 |
主分类号 |
A61K39/002 |
代理机构 |
Morgan, Lewis & Bockius LLP |
代理人 |
Morgan, Lewis & Bockius LLP |
主权项 |
1. An isolated antigenic polypeptide, comprising at least a consensus LSA-5 peptide of sequence EEVVEELIEEVIPEELVL (SEQ ID NO: 15). |
地址 |
Singapore SG |